Skip to main content

Table 2 Demographics and Clinical Characteristics of Participants

From: Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests

 SMA (N = 61)HC (N = 25)PC (N = 15)
ESWT
(N = 15)
ESBBT
(N = 37)
ESNHPT
(N = 55)
ESTCS
(N = 61)
ESWT
(N = 20)
ESBBT
(N = 20)
ESNHPT
(N = 24)
ESNHPT
(N = 15)
Subtype/ Diagnosis3a: N = 3
3b: N = 11
4: N = 1
2: N = 11
3a: N = 10
3b: N = 15
4: N = 1
2: N = 30
3a: N = 11
3b: N = 14
2: N = 31
3a: N = 14
3b: N = 15
4: N = 1
NANANALGMD:N = 7
BMD:N = 1
DMD:N = 7
Gender (F:M)4:1117:2034:2134:2712:814:615:93:12
Age
(years)
28.4
(12.4)
28.4
(14)
28
(14.4)
28.7
(14.3)
21.8
(9.6)
21.6
(7.9)
21.1
(9.6)
14.0
(3.6)
MRC-scale (44–220)191
(15)
161
(32)
134
(39)
138
(39)
220
(1)
220
(1)
220
(1)
144
(44)
MRC-scale upper limb
(22–110)
98
(8)
86
(14)
75
(18)
76
(17)
11011011079
(21)
Level of ambulationNA: N = 12
CA: N = 2
HA: N = 1
NA: N = 12
CA: N = 2
HA: N = 3
NFA: 1
NOA: N = 19
NA: N = 9
CA: N = 1
HA: N = 2
NFA: 1
NA: N = 42
NA: N = 12
CA: N = 2
HA: N = 3
NFA: N = 1
NOA: N = 43
NA: N = 20NA: N = 20NA: N = 24NA: N = 4
CA: N = 3
NOA: N = 8
  1. ESWT Endurance Shuttle Walk Test, ESBBT Endurance Shuttle Box and Block Test, ESNHPT Endurance Shuttle Nine Hole Peg Test, ESCT Endurance Shuttle Test Combined Score, SMA Spinal Muscular Atrophy, Subtype 3a clinical symptoms < 3 yrs., Subtype 3b clinical symptoms > 3 yrs., HC Healthy Controls, DC Disease Controls, MRC Medical Research Council, LGMD Limb Girdle Muscular Dystrophy, BMD Becker Muscular Dystrophy, DMD Duchenne Muscular Dystrophy, NA Normal Ambulation, CA Community Ambulation, HA Household Ambulation, NFU Non Functional Ambulation, NOA Non Ambulation